This morning, Johnson & Johnson shared its third-quarter 2026 earnings report.
Since its founding in 1886, the company has been committed to innovation—today, approximately 140,000 employees across the globe work to deliver solutions for patients around the world to help profoundly impact health for humanity.
“Our third-quarter performance underscores the importance of a diversified business,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We are very confident in our full-year outlook to surpass $100 billion in annual sales for the first time in our 140-year history. Supported by strong cash flow and disciplined capital allocation, we continue to invest in innovative science and technology to advance patient outcomes, drive future growth and create sustainable, long-term value for shareholders.”
For more details about the company’s third-quarter 2026 results and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.
